Patient pathways and perceptions of hypertension treatment, management, and control in rural Bangladesh: a

Aliya Naheed1, Victoria Haldane2, Tazeen H Jafar3,4

  • 1Initiative for Noncommunicable Diseases, International Centre for Diarrhoeal Disease Research (icddr), Dhaka, Bangladesh.

Insights

Many hypertensive patients in rural Bangladesh know about their condition but lack knowledge on prevention and treatment. Barriers like long waits and poor supplies hinder access to government care, necessitating community health worker involvement.

Area of Science:

  • Public Health
  • Cardiovascular Disease Research
  • Health Services Research

Background:

  • Hypertension is a major global health threat and a leading cause of premature death.
  • Despite effective treatments, many individuals, especially in resource-limited areas, remain undiagnosed and untreated.
  • This study examines patient experiences with hypertension care in rural Bangladesh.

Purpose of the Study:

  • To explore patient pathways to hypertension care in rural Bangladesh.
  • To assess patient knowledge of hypertension prevention and treatment.
  • To identify barriers to accessing and adhering to hypertension care.

Main Methods:

  • Qualitative study involving in-depth interviews with 20 hypertensive patients in rural Bangladesh.
  • Interviews were conducted in Bangla, transcribed, and translated to English.
  • Patient pathways were mapped using QSR NVivo 10 software.

Main Results:

  • Patients were aware of hypertension but had limited knowledge of prevention and treatment strategies.
  • Medication was often taken only when symptomatic, despite awareness of hypertension's importance.
  • Three main care pathways were identified: specialized hospitals, private clinics/pharmacies, and incidental diagnosis during treatment for other conditions.

Conclusions:

  • Barriers to accessing government hypertension care include lack of community screening support, long waiting times, and inadequate treatment supplies.
  • Expanding the role of community health workers in disseminating chronic disease information can improve hypertension care access.
  • Addressing these barriers is crucial for improving hypertension management in rural Bangladeshi communities.
Abstract

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
445
Qualitative Analysis03:46

Qualitative Analysis

For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
24.5K
Qualitative Analysis01:10

Qualitative Analysis

Qualitative analysis is the process of identifying elements, ions, or compounds in an unknown sample. It is the first and most fundamental type of analysis based on the hierarchy of analytical goals. This hierarchy is significant as it provides a structured approach to scientific research, with qualitative analysis serving as the initial step, providing essential information before moving on to quantitative or other forms of analysis.
There are two main approaches to qualitative analysis:...
1.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
613
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
471
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
509